# 500-mg Versus 1000-mg Ceftriaxone for Uncomplicated Gonorrhea Infection

> **NCT07710118** · PHASE3 · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Gonorrhea Infection

## Interventions

- **DRUG:** ceftriaxone 500-mg
- **DRUG:** ceftriaxone 1000-mg

## Key facts

- **NCT ID:** NCT07710118
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2028-12
- **Final completion:** 2029-06
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-07-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07710118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07710118, "500-mg Versus 1000-mg Ceftriaxone for Uncomplicated Gonorrhea Infection". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07710118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*